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I. INTRODUCTION
Tyrone's mother, a heroin addict, leaves him with a neighbor and
does not return. Tyrone, age two, is placed in a temporary foster
home, awaiting his mom's return. He appears healthy, but has fre-
quent colds and severe bouts of diarrhea. His foster mother finally
takes him to the hospital emergency room, where doctors determine
that Tyrone is suffering from Human Immunodeficiency Virus
("HIV") disease, a precursor to the deadly Acquired Immune Defi-
ciency Syndrome ("AIDS"). The hospital refers Tyrone to a pediatric
AIDS clinic. The clinic is conducting a drug trial of IV-IG, which it
believes could benefit Tyrone by strengthening his immune system.
However, when the clinic contacts the local office of the Department
of Social Services responsibile for Tyrone's care, the office informs
them that regulations prohibit enrolling a child in its care in experi-
mental trials. Attempts to reach Tyrone's mother are unsuccessful.
Meanwhile, the foster family caring for Tyrone asks that he be placed
elsewhere, because they cannot cope with a child with such serious
medical problems.
Tyrone's story is one that has occurred repeatedly across the
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AIDS Legal Clinic, Baltimore, Maryland. Many thanks to Clinton Bamberger, Taunya
Banks, Richard Boldt, Karen Czapanskiy, Marc Feldman, Theresa Glennon, Diane Hoffman,
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country over the past several years. In 1990, 42% of children known
to be HIV positive were not living with their parents; 26% had been
placed in foster care, 9% were living with a relative, and 7% were
living with someone other than a relative.' Most of the HIV-positive
children in foster care cannot obtain access to new drug treatments,
still in the experimental stage, which may be their best hope of delay-
ing the impact of their HIV infection. In 1989, for example, of the
785 children in foster care identified as HIV positive (and there are
many more unidentified), only fifteen were enrolled in new drug trials
at a time when such trials were the only hope to treat their infection.2
At the same time, under-enrollment has also delayed the progress of
these drug trials.
The Centers for Disease Control estimates that there are nearly
twenty thousand HIV-positive children in the United States today.3
It also estimates that each year, two thousand children will be born
infected with the virus.4 By the end of 1990, almost three thousand
children had been diagnosed with AIDS.5 Many of these children
will end up in foster care.
Most of these children are from poor, Black, or Hispanic inner-
city communities, hard hit by the AIDS epidemic. These communi-
ties, already overwhelmed by a multitude of problems, are not organ-
ized to combat the disease. Nor have these communities been
involved in the decisionmaking process for combating AIDS. Black
and Hispanic men and women have been vastly underenrolled in trials
of new, promising drugs.6 Many at-risk children receive no medical
1. Telephone Interview with Margaret Oxtoby, M.D., of the U.S. Centers for Disease
Control, in Atlanta, Ga. (Feb. 22, 1991) (discussing the Centers' survey of 14,049 HIV-positive
children in Los Angeles, San Francisco, Massachusetts, New York, Washington, D.C., and
Texas). In some urban areas, statistics are even more dramatic. The general breakdown of
HIV-positive children seen at Albert Einstein College of Medicine in New York City is as
follows: "(a) child lives with his or her natural family (20 to 25%); (b) child is in foster care
(55 to 60%); (c) child lives with relative or other surrogate caretaker (20 to 25%) .. " Karen
M. Hopkins, Emerging Patterns of Services and Case Finding for Children with HIV Infection,
27 MENTAL RETARDATION 219, 221 (1989).
2. Judith M. Martin & Henry S. Sacks, Do HIV Infected Children Have Access to Clinical
Trials of New Treatments?, 5 AIDS & PUB. POL'Y J. 3 (1990); see also U.S. DEP'T OF HEALTH
AND HUMAN SERVICES, FINAL REPORT: SECRETARY'S WORK GROUP ON PEDIATRIC HIV
INFECTION AND DISEASE (1988).
3. Cheryl P. Weinstock, Children with AIDS, FDA CONSUMER, Oct. 1990, at 8, 19.
4. Centers for Disease Control, HIV Prevalence Estimates and AIDS Case Projections for
the United States, MORBIDITY & MORTALITY WKLY. REP., Nov. 30, 1990, at 7.
5. Judy Foreman, Gain Cited in Curbing Youth AIDS Infections, BOSTON GLOBE, Jan.
18, 1991, at 28. Fifty-two percent of these children are Black, and a quarter are Hispanic.
Weinstock, supra note 3, at 9.
6. Government statistics reveal that as of August 1989, Blacks and Latinos accounted for
42% of gdult AIDS patients in the United States, but only 20.4% of patients enrolled in
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care because of the lack of community awareness and the failure of
social services agencies to respond to the epidemic. Children and
their caretakers are unaware of experimental protocols that may bene-
fit them. This ignorance in turn impedes the progress of research to
address their needs.
To ensure that critical medical care decisions are made for these
children in a timely, informed, and compassionate manner, and to
incorporate the interest of the community most affected by these deci-
sions, we need a structure beyond the simple substitution of state for
parental decisionmakers. The system should not permit legal con-
structs and distrust to obstruct the delivery of much needed medical
care.
The United States Department of Health and Human Services
("HHS") regulations for enrollment of children in experimental trials
recognize that where parental consent is unavailable, some "appropri-
ate mechanism" must protect childrens' interests.7 However, the
HHS regulations fail to provide much guidance on what form the
"appropriate mechanism" should take. This Article proposes a mech-
anism to fill that gap.' A committee composed of the child's foster
parent, an HIV-positive person, a health care worker knowledgeable
about HIV disease in children, and a lay advocate from the child's
community should have the authority to make medical decisions in
the child's best interest. HIV-positive children need advocates from
their communities to protect their interests and ensure that they
receive the best possible medical care. Involving members of the com-
munity in the drug trial process has the added benefit of enhancing
communication between the affected community and medical
researchers. It will reduce distrust and provide more oversight of
clinical trials in children.
This Article describes the present foster care system, explains
National Institute of Allergy and Infectious Diseases AIDS trials. Intravenous drug users
accounted for 27.5% of adult AIDS patients, but only 11.3% of the participants in federal
studies. Robert Steinbrook, AIDS Trials Shortchange Minorities and Drug Users, L.A. TIMES,
Sept. 25, 1989, at 1.
In March 1991, a panel of the Institute of Medicine, a branch of the National Academy of
Sciences, noted that Blacks made up 28% of the population with AIDS (and a much larger
percentage of the HIV-infected population), but only 16.9% of those enrolled in clinical trials.
The report recommended that Medicaid and Medicare consider reimbursing AIDS patients for
experimental drugs or associated medical care. INSTITUTE OF MEDICINE, THE AIDS
RESEARCH PROGRAM NATIONAL INSTITUTES OF HEALTH 24-27 (1991).
7. 45 C.F.R. § 46.408(c) (1990).
8. This Article primarily addresses the problems facing those children who contracted
HIV infection at birth. The question of medical decisionmaking for adolescents is a complex
one, addressed elsewhere. See, e.g., Richard L. North, Legal Authority for HIV Testing of
Adolescents, 11 J. ADOLESCENT HEALTH CARE 176 (1990).
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why it has failed to provide HIV-positive children in foster care with
access to medical trials, and offers an improved means of medical
decisionmaking. Part II details why delegation of decisionmaking for
HIV-positive children to courts or temporary foster families is an
undesirable solution. Part III proposes an alternative model, the
committee described above, to facilitate timely decisionmaking in the
child's interest. This model preserves positive aspects of parental con-
sent and adds other elements to facilitate informed and sensitive deci-
sionmaking. Finally, Part IV addresses the limits and function of
committee intervention.
II. FOSTER CARE, MEDICAL TREATMENT, AND THE OBSTACLES
TO ENROLLING FOSTER CHILDREN IN DRUG TRIALS
A. Foster Care and Medical Consent
The state typically places HIV-positive children in foster care
because of parental neglect.9 Neglect may stem from the parents'
drug use, illness, poverty, or lack of resources and education. Most
cases involve a combination of several of these factors. In some situa-
tions state agencies place a child in foster care because of a parent's
death. Sometimes parents who are ill or without resources voluntarily
place their child in foster care.
State agency regulations on parental consent for medical care of
a child in foster care vary, but their general outlines are similar. For
example, if a child has been committed to the Department of Social
Services, or the parents have placed the child in foster care volunta-
rily, most state regulations do not deprive the parents of medical
guardianship for their child. The Maryland system illustrates such
parental consent regulations. The parents retain medical guardian-
ship, but may be asked to sign a consent authorizing the state to
obtain routine or immediate care for the child.10 If the parent does
9. See Phyllis Gurdin & Gary R. Anderson, Quality Care for Ill Children: AIDS-
Specialized Foster Family Homes, 66 CHILD WELFARE 291, 291 (1987). The Child Welfare
League, in its report on HIV infection and children in foster care, recognized the special
problems faced by HIV-positive mothers:
Women, and especially mothers, frequently ignore their own health care while
attending to their child's needs, particularly if the child is also infected with HIV.
Consequently, women delay treatment until the disease has progressed to the
point where they are no longer able to care for a chronically ill child alone. If this
woman happens to be a mother without a critical support system, the child is
often referred for foster placement.
Virginia Anderson, Beyond Medical Intervention: The Power of Family Foster Care, in MEET-
ING THE CHALLENGE OF HIV INFECTION IN FAMILY FOSTER CARE, 2 (Constance M. Ryan
& L. Jean Emery eds., 1991) [hereinafter RYAN & EMERY].
10. 17 Md. Reg. 1875 (1990).
[Vol. 46:379
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not consent, the local department must seek medical guardianship
from the committing court." The local department must notify the
parents of and encourage their involvement in medical decisionmak-
ing and treatment for the child.' 2 If a child remains in foster care for
an extended period of time without parental contact, the state agency
can commence proceedings to terminate parental rights, and the court
may award guardianship to the state foster care agency.' 3 Upon ter-
mination of parental rights, the state agency has authority to consent
to all medical care.' 4
B. HIV-Positive Minority Children in the Foster Care System
Unfortunately, there is a serious shortage of adoptive homes for
Black and Hispanic children, especially those with HIV disease.'"
Thus, even if a child has lost both parents or the state has terminated
parental rights, the child is likely to remain in the foster care system.
Children in foster care can rarely participate in drug trials.
A primary cause of the underenrollment of these children in drug
trials is the inadequacy of the foster care system, which was over-
whelmed even before the impact of HIV disease. Individual agencies
are consistently underfunded and understaffed, and often poorly man-
aged. Social workers have such large caseloads that they often do not
make mandatatory visits to children in their care, much less provide
needed services.' 6 Foster care agencies have difficulty obtaining even
routine medical attention for children in their care.17
11. Id.
12. Id.
13. MD. FAM. LAW CODE ANN. §§ 5-313 to -317 (1990).
14. Id.
15. Shirley Jenkins et al., Ethnic Differentials in Foster Care Placements, Soc. WORK RES.
& ABSTRACTS, Winter 1983, at 41.
16. The evidence in LaShawn A. v. Dixon, Civ. Act. No. 89-1754 (D.D.C. Apr. 18, 1991),
indicated that while agency policy mandated monthly "face to face" visits with each child in
foster care, in 64% of the cases where the plan was to return a child to her home eventually, no
social worker had ever visited the child. In cases where the goal was to place the child in an
adoptive home eventually, there was no evidence of a social worker's visits in 52% of the cases.
The defendant agency admitted that as of October 1990, 149 children in the foster care system
had no social worker assigned to them. Id. at 39.
17. One study revealed that 40% of children in foster care had no immunization records.
Edward L. Schor, The Foster Care System and Health Status of Foster Children, 69
PEDIATRICS 521, 525 (1982). Studies indicate that many preschool children had not been
vaccinated. See Michael B. Mushlin, Unsafe Havens: The Case for Constitutional Protection of
Foster Children from Abuse and Neglect, 23 HARV. C.R.-C.L. L. REv. 199, 208-09 (1988);
Janet Weinstein & Jollie La Fleur, Caring for Our Children: An Examination of Health Care
Services for Foster Children, 26 CAL. W. L. REV. 319, 324 (1990).
The failure of the foster care system to provide adequate medical care was challenged
successfully in the leading case of L.J. v. Massinga, 699 F. Supp. 508 (D. Md. 1988), aff'd, 838
F.2d 118 (4th Cir. 1988). In Massinga, the court approved new procedures for the Department
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Other, more specific reasons explain the underenrollment in drug
trials of HIV-positive children in the foster care system. Many state
agencies require parental consent before they enroll a child in a drug
trial.' 8 Parental consent is sometimes difficult, if not impossible, to
obtain because the agency often loses contact with the parents after a
of Social Services to improve delivery of medical care to foster children. These procedures
included screening the child within 24 hours for treatment of any immediate medical
problems, giving the child a comprehensive physical, developmental, and emotional evaluation
within 60 days of placement, and using a medical passport for each child. Id. at 518. The
court also ordered the agency to develop an integrated, quality system of health care. Id.
In LaShawn A. v. Dixon, Civ. Act. No. 89-1754 (D.D.C. Apr. 18, 1991), the United
States District Court for the District of Columbia found that the D.C. Department of Human
Services harmed the foster children in its care by failing to serve them. The court found, inter
alia, that the agency failed to place children in appropriate foster homes, to monitor
placements, and to make efforts to create permanent placements. Though agency policy
mandated that all children entering foster care undergo a complete medical examination, the
record showed that the agency did not have adequate medical screening facilities. In addition,
44% of the foster children had not had a medical examination since their entry into care. Slip
op. at 39.
The problem of adequate health care for children in foster care is pervasive. See Edward
L. Schor, A Summary of a White Paper on the Health Care of Children in Foster Care: Report
of Colloquium on Health Care for Children in Foster Homes, CHILDREN'S LEGAL RTS. J.,
Summer 1987, at 16, 17. The Child Welfare League of America ("CWLA"), in "Meeting the
Challenge of HIV Infection in Family Foster Care," recognized the tremendous challenge
posed to the Child Welfare System by the HIV epidemic:
Serving children and families affected by HIV poses some of child welfare's
greatest challenges. HIV infection does, however, throw a highly concentrated
light on the deficits in the system. It also thrusts the child welfare system into
what is perceived to be unfamiliar territory, where attention is focused on the
disease and its medical complexities. HIV infection/AIDS is both a medical and
a social problem. One cannot deal with it without dealing with the problems of
poverty, homelessness, and substance abuse. Nowhere is this more evident than
in the families served by child welfare agencies. For this reason, close
collaboration between child welfare and health care professionals is imperative in
all aspects of prevention, planning, policy development, intervention, and
advocacy.
Constance M. Ryan, Introduction to RYAN & EMERY, supra note 9, at x.
18. Illinois, New York, Pennsylvania, and Wyoming have explicit policies that forbid
enrollment of foster children in clinical trials without the consent of their natural parents.
Martin & Sacks, supra note 2, at 3. Although this may be an appropriate response for clinical
trials with no expected participant benefit, most HIV trials do hold out some potential benefit
to participants. These protocols should be reviewed on a case-by-case basis to assess the pros
and cons of participation for each HIV-positive child. The merits of the case-by-case approach
are apparently being recognized in the State of New York, where the commissioner who
oversees foster care may consent to enrollment in cases where an experimental protocol is
essentially the equivalent of medical treatment.
The State of Massachusetts has taken the lead in creating a systematic response to
enrolling foster children in HIV drug trials. The Massachusetts Department of Social Services
created a central AIDS review board to make decisions regarding testing and treatment of at-
risk children in its care. The Board reviews experimental protocols and determines whether it
will permit enrollment of children in its care in each trial. The Board is composed of
professionals, doctors, lawyers, and social workers, and does not provide for substantial
community input. While it certainly is a step in the right direction to create a well-informed
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child is placed in foster care. The parents may be ill, heavily involved
with drugs, or unresponsive to attempts to contact them. They may
have moved without informing the social worker. Whether or not
they require parental consent, state agencies have expressed under-
standable reluctance to enter children into experimental treatment.
Some agencies specifically object to enrolling children in placebo-con-
trolled trials. 19
In addition to inertia, lack of resources, and concerns about
authority and liability, the shadow of the Tuskegee syphilis experi-
ment20 has caused agencies and social workers to distrust the idea of
entering a child into an experimental treatment program. The Tus-
kegee study, which began in 1932 and continued until 1972, involved
observation of the effects of untreated syphilis on a group of poor,
illiterate, black men in rural Alabama." The Public Health Service,
working with the Tuskegee Institute, enrolled these men in a study to
observe the long-term effects of their disease.22 They neither offered
the men treatment, nor informed them of the nature of their illness. 23
Even after penicillin became available, the Public Health Service did
not treat the men, but continued to monitor their conditions for forty
years.24 As of 1969, at least twenty-nine and perhaps as many as 100
men had died as a direct result of complications caused by untreated
syphilis. Others had developed serious syphilis-related heart condi-
tions that may have contributed to their deaths.25
The Tuskegee study has engendered distrust in the Black com-
munity for any experimental treatment program sponsored by the fed-
eral government.26 As Dr. Wayne Greaves, an infectious disease
expert at Howard University Medical School, has said, "Many
[B]lacks and Hispanics see research at universities as ivory-tower
experimentation that is more for the sake of advancing researchers'
prestige than improving patients' care."' 27  Patients often ask Dr.
Greaves for advice when they are eligible for a study. "Particularly
Board to review protocols, the Massachusetts model does not provide alternative solutions to
the difficult question of consent in the absence of parental involvement.
19. Martin & Sacks, supra note 2, at 6.
20. See JAMES H. JONES, BAD BLOOD: THE TUSKEGEE SYPHILIS EXPERIMENT (1981).
21. See id.; ROBERT J. LEVINE, ETHICS AND REGULATION OF CLINICAL RESEARCH 69
(1986); Taunya L. Banks, Women and AIDS--Racism, Sexism, and Classism, 17 N.Y.U. REV.
L. & SOC. CHANGE 351, 361-65 (1989-1990).
22. LEVINE, supra note 21, at 70.
23. Id.
24. Id.
25. JONES, supra note 19, at 2.
26. Gina Kolata, In Medical Research Equal Opportunity Doesn't Always Apply, N.Y.
TIMES, Mar. 10, 1991, at 16.
27. Id.
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when I have to refer them to the National Institutes of Health, they
ask, 'What are they going to do to me? Is this going to be another
Tuskegee?' "28
This history provides an understandable reason to proceed cau-
tiously with enrolling HIV-infected minority children in drug trials.
However, to reject all drug trials out of hand disserves children in
great need of finding treatment for their illness. Drug trials hold the
possibility of useful intervention that may delay the onset of disease.
Still, the risks and potential benefits of each trial must be weighed
individually.
In May 1990, the Food and Drug Administration ("FDA")
approved zidovudine, commonly called "AZT," as the first treatment
for HIV-infected children.2 9 However, researchers across the country
were already conducting trials which revealed the promise of drugs
such as AZT.30 In 1989, for example, three drug trials were in pro-
cess. One treated HIV-positive children with intravenous immu-
noglobulin, which had already proved useful in treating children with
other kinds of immune disorders. This trial, Protocol 045, enrolled
children with relatively mild symptoms of infection. It was a placebo-
controlled trial-that is, some children enrolled in the trial did not
actually receive immunoglobulin. 31  Another trial, Protocol 128,
28. Id.
29. See Weinstock, supra note 3, at 9. The FDA approved children's treatment with AZT
after drug trials conducted under the auspices of the National Institute of Allergy and
Infectious Disease AIDS Clinical Trials Group. The FDA did not require full evaluation of
the effectiveness of AZT in children prior to approving its use. It proceeded on the basis of the
proven effectiveness of AZT for adults and data demonstrating its safe use for children. Id.
30. The Food and Drug Administration had approved AZT for adult AIDS patients in
1987. Id. Available data indicates that AZT slows the progression of AIDS in both children
and adults. Centers for Disease Control, supra note 4, at 7. A recent multi-center study of 88
children with advanced HIV disease concluded that the efficacy of AZT in children is similar
to that in adults. It also noted substantial weight gain and improvement in cognitive function
primarily in children under three. Ross E. McKinney et al., A Multicenter Trial of Oral
Zidovudine in Children with Advanced Human Immunodeficiency Virus Disease, 324 NEW
ENG. J. MED. 1018, 1021-22 (1991). Another study conducted by the Department of Veterans
Affairs found AZT less likely to delay the onset of symptoms in minority patients than in white
patients. Gina Lolata, Federal Study Questions Ability of AZT to Delay AIDS Symptoms, N.Y.
TIMES, Feb. 15, 1991, at Al. However, this study was not designed to determine whether
people of different races would react differently to AZT, and it reached no clear conclusion on
this point. This suggests the need for including more people of color in drug trials, so the
collected data can enhance treatment for all.
31. The positive impact of IV-IG on the children in this study was so dramatic that the
Data Safety Monitoring Board, an independent evaluator, recommended that the study end a
year early. The Board found that the injections were so effective that it would have been
unethical to continue the study, given that some children were receiving only a placebo. The
study concluded that monthly injection of intravenous immunoglobulin dramatically
decreased serious bacterial infections and reduced the number of hospitalizations for children,
though it did not appear to prolong the lives of the children. Foreman, supra note 5. The drug
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tested the efficacy of AZT in the treatment of children. The third
trial, Protocol 103, compared continuous infusion of AZT, oral AZT,
and dideoxyinosine ("DDI"). Slots available in these trials went
unfilled. At the same time, there were at least 785 children in foster
care identified as HIV positive, and only fifteen of these children were
enrolled in any clinical trial, notwithstanding that it was the only
hope for treatment at that time.32 An amended Protocol 103 contin-
ues to be open to enrollment. Only eleven out of seventy-five slots had
been filled as of April 10, 1991. 33
Researchers opened another trial, ACTG 138, to enrollment on
November 5, 1990, but as of April 10, 1991, only fifty-one of the 140
slots had been filled. 34 This trial, designed to evaluate the long-term
safety, tolerance, and efficacy of dideoxycytidine, is open to children
with symptomatic HIV infection who are intolerant to AZT,35 or who
experience disease progression while taking AZT.36
Today, HIV-infected children can receive treatment with AZT
without enrolling in an experimental drug trial.37 IV-IG is now also
available now outside of a drug trial. 38 AZT, however, has side effects
that limit its use in some children.39 Furthermore, its helpful aspects
are limited; apparently AZT merely slows down the progression of
HIV disease. But other, potentially more promising drugs are being
tested.' In addition to possibly beneficial treatment, enrollment in a
drug trial brings other potential benefits, including developmental
screening every six months and state-of-the-art care and monitoring.
As treatment options grow, HIV-infected children need advocates
who are aware of new developments and can consider whether enroll-
ment in a trial is in the child's best interests.
III. OPTIONS FOR CHANGING THE STATUS Quo
How can we ensure children's access to potentially beneficial
company involved, Miles, Inc., a unit of Bayer, agreed to provide the drug free of charge to all
participants when the study ended. Financial Section, Reuters, Jan. 17, 1991, available in
LEXIS, Nexis Library, Wires File.
32. Martin & Sacks, supra note 2, at 3.
33. Search of AIDS Trials Database, Clinical Trials Info. Serv., Rockville, Md. (Apr. 25,
1991) (search for pediatric trials ACTG 103 and ACTG 138).
34. Id.
35. Id.
36. Id.
37. See Weinstock, supra note 3, at 9.
38. See Foreman, supra note 5.
39. AZT can inhibit the production of red blood cells, which are necessary for oxygen
transport. It also may reduce the number of white blood cells. Weinstock, supra note 3, at 10.
40. Id.
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drug trials, while protecting them from harmful experimentation?
Much progress has been made in addressing the abuses in medical
research since the Tuskegee syphilis experiments. Today an institu-
tional review board must review and approve research protocols
funded by the federal government and every subject must provide
detailed, informed written consent.4 HHS regulations provide guide-
lines that must be met before an institutional review board can
approve a particular research plan.4 2 The regulations also mandate
what researchers must disclose and explain in an informed consent
form to be signed by the patient.43 HHS regulations thus provide a
two-pronged check on research studies, consisting of an institutional
review board and informed consent. For those from whom it is
impossible to obtain truly informed consent, the Department of
Health and Human Services has promulgated additional guidelines to
prevent injury or unethical exploitation. 44
The HHS regulations require parental permission before enroll-
ing a child in an experimental protocol.45 If appropriate, depending
on the child's age and level of maturity, the regulations also require
the child's assent.46 If permission of the parent or guardian is not
reasonable under the circumstances, the regulations authorize the
institutional review board to develop an "appropriate mechanism" to
protect the children involved .4  However, the HHS regulations do
not define the appropriate mechanism that they authorize.
The critical issue for children in foster care is who can provide
informed consent for the child in the absence of the parent? A tradi-
tional option used in a few states is to ask a court to authorize the
child's enrollment in a drug protocol.49 However, several problems
arise with this method. First, the agency responsible for the child's
care must initiate the court proceeding. As previously noted, social
services and foster care agencies are typically under-funded and over-
worked, and hardly able to provide routine health care to many foster
41. 45 C.F.R. § 46.103 (1990).
42. Id. § 46.111.
43. Id.
44. See, e.g., id. § 46.205 (1990) (fetuses, pregnant women, in vitro fertilization); id.
§ 46.305 (prisoners); id. § 46.401-.409 (children).
45. Id. § 46.408(b).
46. Id. § 46.408(a).
47. Id. § 46.408.
48. Id. § 46.408(c). The only guidance the HHS regulations provide is that the choice of
an appropriate mechanism depends on the nature and purpose of the activity described in the
protocol, whether there is an anticipated benefit to the research subject, and the ages, maturity,
status, and condition of the participants. Id.
49. Martin & Sacks, supra note 2, at 3.
[Vol. 46:379
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children. 50 Having to prepare petitions and proceed to court for
many HIV-positive children is an unnecessary and time-consuming
drain on resources. Timeliness is imperative in medical decisionmak-
ing. Given the likely lag time at social services and the crowded court
dockets in most areas, timely decisions by the courts are unlikely.5
Besides, a judicial decision to enter a child into a drug trial does not
end the matter. Someone must monitor the child's progress in the
trial, and keep up with new options for the child's treatment as they
become available. Courts are ill-suited for this role. Furthermore,
resorting to court action in every such instance is expensive and
resource-consuming for the judicial system.
Perhaps the biggest drawback to having courts decide whether to
enroll a child in a drug trial is the increasing recognition that courts
are not necessarily the best arbiters of discretionary moral judg-
ments.5 2 There may not be a clear right or wrong answer to a ques-
tion of whether to enroll a child in a drug trial. Rather, it is a
personal decision, one that those who best know the child should
make.
Another option is to delegate decisionmaking authority to the
foster parent caring for the child. At least one state court has ordered
this procedure.53 A difficulty with this method is that the child may
move frequently from foster home to foster home.54 Though the fos-
50. See supra part II.B.
51. See Herman Mendez & Jose E. Jule, Care of the Infant Born Exposed to Human
Immunodeficiency Virus, 17 OBSTETRICS & GYNECOLOGY CLINICS N. AM. 637 (1990).
52. Commentators have recognized limitations of court involvement in questions of
withdrawal of life support from a terminally ill or permanently unconscious patient.
[T]he judicial process has limited value in handling bioethical conflicts, such as
withholding life-sustaining treatment or allocating scarce medical resources.
First, legal services are expensive, and the judicial system's bureaucratic,
adversarial approach is not designed to address the emotional issues faced by
patients and health care professionals struggling with life-threatening issues.
Second, the legal system often is not responsive to the time pressures of ethical
conflicts in medicine. Courts often announce decisions months after the patient
has either died or left the hospital. Finally, retrospective court judgments do not
fulfill health professionals' need for hospital policies to help resolve ethical
problems before they reach an impasse.
Janet Fleetwood et al., Giving Answers or Raising Questions?: The Problematic Role of Institu-
tional Ethics Committees, 15 J. MED. ETHICS 137, 138 (1989). The Supreme Court of Minne-
sota held that judicial approval was unnecessary where each ethics committee had reviewed
and agreed with a family's decision to withdraw life prolonging treatment from a patient in a
persistently vegetative state. In re Torres, 357 N.W.2d 332 (Minn. 1984).
53. In Maryland, foster parents have the authority to consent to a foster child's enrollment
in a clinical trial by court order. Martin & Sacks, supra note 2, at 3.
54. One of the named plaintiffs in LaShawn A. v. Dixon, Civ. Act. No. 89-1754 (D. D.C.
Apr. 18, 1991), had been in six different foster homes and one group home. Id. at 32. Another
named plaintiff, Kevin, was a "special needs" child who had been placed in congregate care as
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ter parents should have a say in the decision, it should not be their
decision alone, except in a long-term care setting or where the family
plans to adopt the child. The level of a foster parent's involvement
with a child varies dramatically from family to family. Foster parents
may also experience a conflict between their other children and
responsibilities, and the demands of enrolling a child in a clinical trial,
which frequently involves extended monthly clinical visits. Addition-
ally, because of the difficulty of finding foster parents for HIV-positive
children, ever increasing numbers of these children are in group
homes awaiting placement."
We need an alternative decisionmaking mechanism. The present
model relies heavily on parental consent. Is it possible or desirable to
duplicate the parental role in this context? We must examine the
rationale for deference to the parent in medical decisionmaking. Does
informed consent by a parent really protect children? If so, how?
The history of deference to a parental decisionmaker is complex.
It began with the notion that the child was an extension of, or prop-
erty of, the parent. Under the common law doctrine, the parent had
an absolute right to control the child and was financially responsible
for the child.56 An injury to the child was an injury to the parent. 57
This notion of the child as the parents' property has only recently
changed.
Courts now justify giving parents the right to make decisions for
their children by recognizing that "natural bonds of affection lead
parents to act in the best interests of their children.""8 Courts
acknowledge parents' continuing responsibility for their child and
make assumptions about the parent-child relationship. They assume,
for instance, that parents love their children and care about what hap-
pens to them. Courts also presume that parents and their children
share a common family and ethnic history. Because of this, the courts
an infant, and then moved from three different foster homes that had indicated plans to adopt
him. Id. at 32.
55. See id. at 33; Hopkins, supra note 1, at 221.
56. Linda S. Ewald, Medical Decision-Making for Children: An Analysis at Competing
Interests, 25 ST. Louis U. L.J. 689, 689-95 (1982); Francis B. McCarthy, The Confused
Constitutional Status and Meaning of Parental Rights, 22 GA. L. REV. 975, 975-80 (1988);
Mason P. Thomas, Jr., Child Abuse and Neglect Part I: Historical Overview, Legal Matrix and
Social Perspectives, 50 N.C. L. REV. 293, 293-95 (1972).
57. For example, a Michigan court held a surgeon who operated on a child without
parental consent liable in an action for battery by the parent. Zoski v. Gaines, 260 N.W. 99
(Mich. 1935); Rishworth v. Moss, 159 S.W. 122 (Tex. Civ. App. 1913); see also Eric S. Engum,
Expanding the Minor's Right to Consent to Non-Emergency Health Care, 3 J. LEGAL MED. 557
(1982); Ewald, supra note 55, at 689-95; McCarthy, supra note 55, at 293-95.
58. Parham v. J.R., 442 U.S. 584, 602 (1979), quoted in Stanley N. Katz, Legal History
and Family History: The Child, the Family, and the State, 21 B.C. L. REV. 1025, 1026 (1990).
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reason that parents know the child best and will advocate the child's
best interests. Deference to parents, however, is not due entirely to
the assumption that parents love their children and act in their best
interests. Courts also consider separate values of family privacy and
parental autonomy, which may conflict with the child's best
interests.9
When parents are unavailable or have been disqualified from
decisionmaking for their children, courts often apply a "substituted
consent" or a "best interests" test. The concept of substituted consent
is not particularly meaningful in the case of a very young child
because it is difficult, if not impossible, to ascertain what the child
would want if she were competent to make a medical decision. The
disadvantage of the best interests test is its vagueness. The Hastings
Center 6O has provided helpful guidelines for applying the "best inter-
ests of the child" test and for determining who should make treatment
decisions for severely ill newborns:
1. Priority should be given to those most likely to advance
the interest of the child.
59. The notion of parental autonomy has constitutional dimensions. In Meyer v,
Nebraska, 262 U.S. 390, 400-01 (1923) and Pierce v. Society of Sisters, 268 U.S. 510, 534-35
(1925), the Supreme Court stressed the importance of parental autonomy in decisions about
education for their children. The Court, however, recognized that it must balance a
countervailing state interest in the child's welfare. In Prince v. Massachusetts, 321 U.S. 158
(1944), for example, the Court held that a parent's religious principles could not overcome the
state's interest in protecting a child's welfare where child labor was involved.
In the more recent case of Wisconsin v. Yoder, 406 U.S. 205 (1972), the Supreme Court
upheld the right of Amish families to prevent their children from continuing with public
education beyond eighth grade. Only the dissent in Yoder recognized that the child had a
separate interest that the Court should recognize. Id. at 241 (Douglas, J., dissenting).
Recent cases involving minors and the right to an abortion have recognized a child's
separate interest. In Planned Parenthood v. Danforth, 428 U.S. 52, 75 (1976), and Bellotti v.
Baird, 443 U.S. 622 (1979), the Supreme Court recognized that a child has a privacy interest
separate from her parents that must be considered in the abortion context. A "mature minor"
is capable of making an informed decision about whether or not to have an abortion, and her
privacy must be respected.
Another important concept in the Supreme Court abortion cases, including Danforth and
Bellotti, is that a parent may not always make a decision in the child's best interests, and that
this necessitates some review or involvement by some other authority figure. Danforth, 428
U.S. at 74; Bellotti, 443 U.S. at 647. In Parham v. J.R., 442 U.S. at 606, 617, the Court found
that Georgia's procedures for allowing a parent to commit a child to a psychiatric institute met
due process standards, although the Court recognized the need for a check on parental
authority. The Court found that review by the medical director to ascertain the necessity of
committing a child to a psychiatric facility was sufficient review of parental decisionmaking.
Id. at 613-17.
60. The Hastings Center, founded in 1969, is composed of individuals concerned with
medical and professional ethics, including physicians, nurses, lawyers, administrators, public
policymakers, and other academic and health care professionals. The Center conducts
research and funds national and international fellowships. It publishes the Hastings Center
Report and IRB: A Review of Human Subjects Research on a bi-monthly basis.
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2. Those intimately involved in the day-to-day care of the
child must have a major role in decision-making.
3. Someone knowledgeable about the child's medical prob-
lem and experienced in dealing with such problems should
participate.
4. Finally, someone who is able to look at the facts compre-
hensively and impartially should also be involved in making the
decision.6'
The authors of the Hastings Report acknowledge that fulfilling
all of these criteria will probably involve more than one or two per-
sons. Although the authors recommend giving the child's parents pri-
mary decisionmaking authority, they recognize that parents often
need the support of medical professionals when making difficult
decisions.62
IV. AN ALTERNATIVE MODEL OF DECISIONMAKING FOR HIV-
POSITIVE CHILDREN IN FOSTER CARE
Alternative decisionmakers should attempt to replicate the posi-
tive aspects of parental consent and incorporate the criteria identified
as essential by the Hastings Center. They should know the child well
and act out of concern for the child. They should know about HIV
and medical treatment options and review the child's progress fre-
quently. They should maintain objectivity in determining what action
is in the child's best interests. To properly consider experimental
treatment for HIV-positive children without parents to advocate for
them, decisionmakers also should be sensitive to the historic role of
race and class bias in medical experimentation, a lesson learned from
the Tuskegee syphillis study.
Finding any one person who embodies all these qualities may be
impossible. Thus, I propose an alternative model: granting medical
61. Imperiled Newborns, HASTINGS CENTER REPORT, Dec. 1987, at 5, 17. The CWLA
Task Force on Children and HIV Infection recognized the importance of multidisciplinary
involvement with HIV-infected children. Coordination of social services and medical services
is imperative for successful family foster care placement of HIV-infected children. Pediatric
HIV infection is a complex disease that requires ongoing partnerships among the child welfare
agencies, the health care system, the child, the foster family, and, ideally, the biological family
to provide support and continuity of care. Agencies and foster parents, including kinship
caregivers, need access to knowledgeable health care providers who can deliver quality care
and answer their medical and health questions. The best interests of the child dictate that the
goals and functions of the social service and health effort be congruent.
62. Id. at 17-19. Where the benefits of treatment for seriously ill newborns are unclear, the
President's Commission for the Study of Ethical Problems in Medicine and the American
Academy of Pediatrics recommends that infant ethics committees review treatment decisions.
Many hospitals across the country use these committees to review treatment decisions for
severely ill or disabled infants. Id. at 21.
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guardianship of foster children to a small committee that combines all
of these attributes. This group would include the foster parent caring
for the child (if any),63 a health care worker (pediatrician, nurse prac-
titioner, physician's assistant) familiar with HIV infection in children,
an HIV-infected individual, and a lay advocate from the child's
community."M
The foster parent would be intimately involved in caring for the
child and could bring day-to-day familiarity with the child to the
decisionmaking process. The foster parent would also be in the best
position to monitor the child's health and well-being and to observe
the impact on the child if the committee decided to enroll the child in
a medical trial.
The health care worker would be knowledgeable about the
child's medical problems and have experience in dealing with HIV
disease. Because of a potential conflict of interest, the health care
worker selected could not be involved in the medical research.
Including a health care worker in the decisionmaking process is par-
ticularly important because many HIV-positive children do not have
regular contact with a primary care physician, much less one who is
knowledgeable about HIV.
An HIV-positive person could provide an important perspective
for the committee on the experience of living with HIV disease and
the acceptable level of risk when one is faced with a terminal illness.
As the authors of the Hastings Report noted, the best interests of the
child standard should not be based on the sensibilities of an
unimpaired adult.65 Rather, it should be based on the sensibilities of
an HIV-positive person.
Finally, the lay advocate on the committee would be an individ-
ual from the child's community-ideally of a similar racial, class, and
religious background)-who could bring the values and concerns of
the child's community to the decisionmaking process. The lay advo-
cate would be someone experienced with young children, such as a
parent, teacher, or day care worker. Involving a community member
in decisionmaking would provide additional oversight of the clinical
trials process, and would enhance communication and reduce distrust
between the community and the medical researchers.
Although it may be controversial, involving the community in
63. If a child is living in a group home, a care provider from that home would take the
place of a foster parent on the committee.
64. The lay advocate and the HIV-positive individual could be the same person in some
instances.
65. Imperiled Newborns, supra note 61, at 15.
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decisionmaking for HIV-positive children is a critically important
part of this proposal. Almost half of all HIV-positive children do not
live with their parents.66 In many of these cases the parents are dead,
in prison, or struggling with drug habits that make it impossible for
them to care for their children. The state has already shown itself to
be a poor parental substitute. Members of the child's community can
help fill the parental role. They can bring the values of the child's
community to the decisionmaking process, as the child's parents
might have done. In addition to advocating for the individual child,
these representatives could help alleviate race and class bias in drug
trials with these children.
Poor, predominantly Black and Hispanic inner-city communities
have a great interest in finding successful treatment for HIV infection.
To date, these communities have not been sufficiently involved in the
treatment research. Their informed involvement is essential to the
success of this research. These communities and their children need
vigorous advocates to keep them abreast of medical and research
developments and make informed choices about the avenues to pur-
sue. The gay community has successfully forced changes in research
on terminal illnesses.67 Similar community advocacy and involve-
66. In some cases, members of the child's extended family offer support when the parent
dies or becomes incapacitated. Where an extended family member is caring for a child, the
intervention by a committee as proposed here may be unwarranted. The strength of the
extended family has long been an important feature of Black and Hispanic communities. The
role of the neighborhood and community has also been an important feature, though one
eroded in recent times. All of these structures should be supported and encouraged.
Unfortunately, the extended family is often unable to help the child. Grandparents and other
relatives frequently have difficultly obtaining the financial support they need to assist them in
caring for an HIV-infected child. Their authority to make medical decisions for the child in
the parent's absence is often unclear.
A study of a poor urban Black community in the late 1960's describes kinship networks
typically involved in raising a child. Though these relationships are not legally authorized or
recognized, they nevertheless play an important role in the child's life and well-being. CAROL
B. STACK, ALL OUR KIN: STRATEGIES FOR SURVIVAL IN A BLACK COMMUNITY (1974). A
similar kind of kinship network exists in the Native American community, which state
authorities have not typically respected. Social workers would consider a child neglected or
abandoned when a parent left a child with a relative outside of the nuclear family. H.R. REP.
No. 1386, 95th Cong., 2d Sess. 10 (1978), reprinted in 1978 U.S.C.C.A.N. 7530, 7532.
However, in a Native American community, "there is no such thing as an abandoned child
because when a child does have a need for parents for one reason or another, a relative or a
friend will take that child in. It's the extended family concept." Problems that American
Indian Families Face in Raising Their Children and How These Problems Are Affected by
Federal Action or Inaction: Hearings Before the Subcommittee on Indian Affairs of the Senate
Committee on Interior and Insular Affairs, 93d Cong., 2d Sess. 5, 473 (1974) (statement of Sen.
Abovrezk).
67. Harold Edgar & David J. Rothman, New Rules for New Drugs, the Challenge of AIDS
to the Regulatory Process, 68 MILBANK Q. 111, 122-24 (Supp. 1 1990). Gay advocates reacted
with fury to the slow pace at which new therapies for HIV disease were being tested. They
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ment would allow comparable progress for HIV-infected children.
Substantial authority exists for recognizing a community's inter-
est in decisions affecting its children and appointing someone other
than a parent to serve as a child's advocate.6" The Indian Child Wel-
fare Act of 1978 ("ICWA"), for example, provides that tribal courts
have the ultimate authority to decide where to place Indian children
domiciled on their reservations if they are removed from their parents
or voluntarily relinquished for adoption.69 Congress enacted the
ICWA because of concerns that state authorities who were ignorant,
or even contemptuous, of Native American culture and values were
removing Native American children from their homes and placing
them in white environments. The removal of these children
threatened their tribal integrity and welfare.7 ° In response, the Act
placed authority for decisionmaking with tribal courts. 71
In Mississippi Band of Choctaw Indians v. Holyfield,72 the United
States Supreme Court reversed a Mississippi court decision permitting
Native American parents to place their child for adoption with a
white family off the reservation. Interpreting the ICWA, the Court
stressed the Native American community's interest in deciding where
to place children of the tribe.73 The Court found that the parents'
decisionmaking in this circumstance gives way to the statutory pro-
argued for a less paternalistic system where informed consumers could make their own
choices. The FDA responded by taking steps to allow more widespread use and testing of new
drugs. See Michael Specter, Pressure from AIDS Activists Has Transformed Drug Testing,
WASH. POST, July 2, 1989, at Al.
68. 20 U.S.C. § 1415(b)(l)(B) (1988). The Individuals with Disabilities Education Act
explicitly recognizes that situations will arise where a parent cannot act as an advocate for her
child. The Act authorizes the appointment of a parent surrogate who can act on the child's
behalf for educational decisions. This system has been criticized because the surrogate parent,
appointed by the school board, may not be sufficiently independent to be a good advocate for
the child. This suggests that creating committees to represent the interests of HIV-positive
children is probably best done under the umbrella of an agency other than the foster care
system or U.S. Department of Social Services, such as the states' department of health.
69. 25 U.S.C. 1911(a) (1988).
70. See H.R. REP. No. 1386, 95th Cong., 2d. Sess. 8-11 (1978), reprinted in 1978
U.S.C.C.A.N. 7530, 7530-33.
71. 25 U.S.C. § 1911 (1988).
72. 490 U.S. 30 (1988).
73. The Court quoted at length from In re Adoption of Halloway, 732 P.2d 962 (Utah
1986):
To the extent that [state] abandonment law operates to permit (the child's]
mother to change [the child's] domicile as part of a scheme to facilitate his
adoption by non-Indians while she remains a domiciliary of the reservations, it
... weakens considerably the tribe's ability to assert its interest in its children.
The protection of this tribal interest is at the core of the ICWA, which recognizes
that the tribe has an interest in the child which is distinct from but on a parity
with the interest of the parents.
Id. at 969, quoted in Holyfield, 490 U.S. at 52.
1991]
UNIVERSITY OF MIAMI LAW REVIEW
tection vesting these decisions with the tribal court.74
The ICWA and Holyfield reflect several important concepts.
They recognize the importance of a child's racial and cultural ties;
decisions made by even a well-meaning white, middle class person
rely on a different value system and may ultimately harm a child of a
different background. They also acknowledge that sometimes a com-
munity's interest in its own survival overrides the birth parents' rights
to determine their children's future. Finally, both the ICWA and
Holyfield reflect an understanding by Congress and the Supreme
Court that at times the community can make a decision more in har-
mony with the child's best interests than a parent would make.
My proposal to include community members in the decisionmak-
ing process for HIV-positive children addresses concerns similar to
those underlying the ICWA and Holyfield. The involvement of a
community representative will help insure that racism and class bias,
however subtle or inadvertent, do not negatively effect decisionmak-
ing for the HIV-positive child. It is true here as well that the commu-
nity has an interest in the welfare of its children and that it may act to
protect that interest.
Admittedly, the analogy between this situation of HIV-infected
children and Native Americans is imperfect. Native Americans, at
least those living on reservations and subject to the jurisdiction of tri-
bal courts, are a truly separate community in a way that Black and
Hispanic communities are not. Yet concerns about the impact of
racial and cultural bias on the vitality of a community are equally
pressing in both settings. In addition, the notion that a community
has the right and the responsibility to advocate on behalf of its least
powerful members is valid in each context. However, in light of the
differences between Black and Hispanic communities and the Native
American tribes, I do not propose that the community could override
a parent's decision, as the ICWA authorizes. Rather, the community
should step in only when the parent consistently has failed to act.
In other situations, courts have recognized that parents may not
always be in a position to protect their children's welfare. In Ad Hoc
Committee of Concerned Teachers v. Greenburgh #11 Union Free
School District,7" the United States Court of Appeals for the Second
Circuit allowed a teachers' committee to represent the interests of
Black and Hispanic students in a challenge to the discriminatory hir-
ing policy of their school. The case involved a residential public
school with a majority of Black and Hispanic children. Their teach-
74. Holyfield, 490 U.S. at 51-53.
75. 873 F.2d 25 (1989).
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ers, who were white, Black, and Hispanic, alleged that the school dis-
criminated against people of color in hiring teachers and that this
practice harmed the children.76 Many of the children were in foster
care placements, though three-fourths of them eventually returned to
their families. 7 The court granted "next friend" status to this ad hoc
teachers committee under Federal Rule of Civil Procedure 17,78 find-
ing that the teachers were best suited to represent the children's inter-
est. The teachers had first-hand knowledge of the children's needs,
their interest in representing the children apparently arose out of a
good faith concern about the children's welfare, and they had no
apparent conflict of interest with the children's concerns.7 9 Finally,
and perhaps most important, the court found that the teachers were
the only group likely to attempt to vindicate the children's rights.80
An analogy exists between the teachers committee in Greenburg
and the committee proposed in this Article. A committee composed
of the foster parent, an HIV-positive person, a health care worker,
and a community representative would have first-hand knowledge of
the child's needs, a good faith concern for the child's welfare, and also
would be the only group likely to vindicate the child's right to seek
medical care.
The role of the committee I propose differs from the teachers'
committee in Greenburgh. The proposed committee would make
medical decisions for individual children that would have a direct
impact on their welfare. However, there are similar reasons for
authorizing the committees. Greenburgh supports the notion that
community members other than parents may play a role in asserting
rights on behalf of children otherwise powerless to assert these rights
themselves. The ultimate goal, both in Greenburgh and the commit-
tee proposed here, is to have a positive impact on the climate in which
the children receive care.
Theoretically, a conflict of interest could arise between the com-
munity's welfare and the welfare of an individual HIV-positive child.
The community arguably has an interest in getting as many children
as possible into clinical trials to increase the pace of research,
although it may not be in each child's best interests to be enrolled in a
drug trial. There are three responses to this potential conflict. First,
the community representative is only one of four people charged with
76. Id. at 27.
77. Id.
78. Id. at 30.
79. Id.
80. Id.
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making this decision. Second, the committee's charge is to make a
decision in the interest of an individual child only. Finally, HHS reg-
ulations provide children with some protection. The regulations
allow foster children to be enrolled only in protocols with prospects of
personal benefit to the child.81 Under the HHS regulations, a child
can be enrolled in a study with no prospect of personal benefit only if
the risk of the study is minor and an independent advocate, in addi-
tion to another individual acting as a guardian or in loco parentis, is
appointed to protect the child's interest.
8 2
The committee's decisionmaking authority will increase as
parental involvement decreases. In the situation where a child's
placement in foster care is due to temporary inability of a parent to
care for the child, and the parent maintains frequent and consistent
contact with the child, there probably will be no need or justification
for committee intervention. However, even in such a circumstance,
the committee may be a valuable resource to assist the parent in deci-
sionmaking. The child's parent could receive information from the
foster parent on the committee about the child's day-to-day health
and well-being, and could receive medical advice on HIV disease and
the available treatment and protocol options from the health care
worker on the committee. At the opposite end of the spectrum, where
both parents have died or abandoned the child, the committee would
have full authority and responsibility to act.8 3
The most difficult situation arises where the state places a child
in foster care because of neglect or abuse, and parental involvement is
unpredictable and inconsistent. In this situation, the committee must
still respect the parents' right to make decisions for the child.8 4 How-
ever, when the parents' inaction deprives the child of potentially bene-
81. 45 C.F.R. 46.401-.409 (1990).
82. Id. § 46.409.
83. See, e.g., MD. FAM. LAW CODE ANN. §§ 5-313 to -317 (1990).
84. Parents have an interest in their child distinct from consideration of the child's best
interests. A court cannot terminate parental rights absent a showing of unfitness or
abandonment. As the Supreme Court held in Santosky v. Kramer, 455 U.S. 745 (1982),
natural parents do not lose their fundamental liberty interest in the care, custody, and
management of their children because they have not been model parents or have temporarily
lost custody to the state.
Nevertheless, parents cannot exercise their rights in a manner that would endanger the
lives of their children. In cases where a parent's religious beliefs would prevent a life saving
blood transfusion to a minor, courts have ordered the transfusion for the child. Jehovah's
Witnesses in the Washington v. Kings County Hosp., 278 F. Supp. 488 (W.D. Wash. 1967),
aff'd, 390 U.S. 598 (1968). The state can also override a parent's wishes when public health is
at issue. For example, most states require that children be immunized before attending public
schools. In Jacobson v. Massachusetts, 197 U.S. 11 (1905), the Supreme Court recognized the
police power of the state to require immunizations, though it noted that exemptions for
medical reasons might be appropriate.
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ficial medical treatment, the committee would have the right to act.
One of the primary justifications for deferring to the parents in medi-
cal decisionmaking is the assumption that they are in close contact
with the child and know the situation well. Where parents no longer
have consistent contact with the child, they may not have the knowl-
edge to make appropriate decisions for the child. Though courts typi-
cally defer to parental decisions on medical issues, where the child's
life is endangered, courts have intervened. s5
In situations where parents' failure to respond to attempts to
contact them would result in an inability to deliver appropriate medi-
cal care to the child, the committee would be authorized to act.86
Such action could include consenting to enrollment in a clinical trial,
but only when this option holds the best hope for treatment for the
child, and the risks and potential side effects do not outweigh the
potential benefit to the child. The goal is not to create an adversarial
situation between the parent and the committee, or to override paren-
tal decisionmaking, but simply to ensure that someone makes timely
decisions about the child's medical treatment. 7
85. In one case, the parents of a child suffering from leukemia refused to continue the
child's chemotherapy treatment, opting instead for an experimental treatment of questionable
value. The court intervened and ordered continued chemotherapy. Custody of a Minor, 379
N.E.2d 1053 (Mass. 1978), aff'd on reh'g, 393 N.E.2d 396 (1979). The court found that
chemotherapy had a 50% chance of prolonging the child's life for at least five years. Id. at
1057. In a New York case around the same time, the parents presented medical testimony
supporting their use of alternative treatments. In re Hofbauer, 411 N.Y.S.2d 416 (App. Div.
1978), aff'd, 393 N.E.2d 1009 (N.Y. 1979). The court allowed the parents to continue this
alternative treatment with the caveat that if the child's condition worsened, they must use
traditional treatment. Id. These cases appear to depend substantially on the parent's ability to
bring a persuasive medical expert to support their treatment choices. See Karen H.
Rothenberg, Medical Decisionmaking for Children, 1 BIOLAW § 8-2.4(d), at 155 (James F.
Childress et al. eds., 1989).
86. A question could be raised as to whether the state can simply outline by regulation
when committee decisionmaking is authorized or whether a court must authorize such
intervention on a case by case basis. I would argue that regulations could authorize the
committee to act after it has made substantial efforts to contact the parent (including phone
calls, letters and visits to the parent's last known address) without success over a period of
three months (or a shorter period if mandated by the child's health status). The committee
would notify the parent in writing of its intention to assert decisionmaking authority and the
parents would have the right to a hearing to challenge this assertion. However, the burden
should be on the parent to initiate this proceeding.
87. As someone who often represents HIV-positive parents in proceedings where the state
seeks to remove their children for alleged neglect, I do not intend to advocate further erosion
of these parents' rights and involvement in decisionmaking for their children. I am also
concerned that the alleged neglect becomes a self-fulfilling prophecy once the child is removed
from his parent. The United States Department of Social Services often does little to
encourage parental visits, and may inadvertently frustrate these visits. For example, HIV-
positive children in Baltimore, Maryland, are sometimes placed in a group home in Harford
County, making visits with the parent difficult if not impossible. In addition, some social
workers appear to believe that where a parent is HIV-positive, death is imminent, and
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The proposed committee would consist of volunteers"" appointed
and trained by the state health department. A committee independ-
ent of the Department of Social Services is more likely to develop a
trusting relationship with family members who wish to be involved. 9
The committee would meet as often as needed, depending on the
child's status. Each committee could make decisions for more than
one child.
The committee's objective would be to keep informed about the
options available to the child and to make medical decisions in the
child's interest, including enrollment in experimental drug trials,
when appropriate. The committee would weigh the potential benefits
of a drug trial against the burdens, including possible side effects,
additional doctor visits, and possible discomfort resulting from medi-
cal procedures. The committee would consider the impact of all these
factors on the particular child and would consult with the child to the
degree possible, given the child's age and maturity. The committee
also would compare the relative benefits and burdens of a clinical trial
to any established treatment available to the child. The committee
might also consider, just as a parent might, the potential benefit of the
child's participation in a drug trial to the progress of medical
research. Of course, the committee's primary concern at all times
would be the best interests of the child.9°
reunification or consistent contact is unimportant. In fact, a person who is simply HIV-
positive has a substantial life expectancy. Even where the parent is ill, perhaps dying, it is in
the child's interest to maintain as much contact with the parent as possible.
To address these concerns, I suggest that when the state places an HIV-positive child in
foster care, it should immediately appoint a committee to work with the parent in medical
decisionmaking. The parent would not have to accept the committee's input. But the parent
would be informed of the committee's right to step in and make decisions in the event that a
parent fails to maintain contact with the child, and the committee, after reasonable attempts,
cannot reach the parent.
88. The provision of some compensation to committee members obviously would make
recruiting volunteers easier. At the least, the state should provide reimbursement of expenses
and provisions for day care for committee members' children.
89. The best time to assign a committee to an HIV-positive child is upon the family's first
contact with local child protective services. The committee could work with parents to help
them understand HIV disease and the range of treatment available. The committee would not
override the parent's decisions, but would make decisions with the parent or in the parent's
absence.
Families with HIV infection often come to the attention of Protective Services because of
a report by a medical provider concerned that an HIV-positive child is not getting appropriate
care due to missed medical appointments. Appointing a committee to work with the parent
could prevent the child's removal in the first instance, which would be the most desirable
result.
90. It would not be appropriate for the proposed committee to authorize a child's
enrollment in a trial which held no potential benefit to the individual child. At least one
commentator has questioned whether even a parent has the right to make this decision for his
HIV-POSITIVE CHILDREN
In promulgating regulations to protect research subjects, the
Department of Health and Human Services has recognized that where
a child is a ward of the state, simply allowing the child's guardian to
make decisions may not sufficiently protect the child. In particular,
when enrolling a child in an experimental trial that involves a sub-
stantial risk or does not hold out the prospect of direct benefit to the
individual child, HHS regulations require appointment of an advocate
for each child, in addition to another person acting as guardian or in
loco parentis.9 The advocate must be someone who has the back-
ground and experience to act in the child's best interests. This person
also must agree to act in the child's best interests for the duration of
the child's participation in the research and must not be associated
with the research of the guardian organization.92
V. CONCLUSION
HIV-positive children in foster care need advocates who will
work to see that they receive the best medical care available. In many
cases this may involve consenting to enroll a child in an experimental
drug trial, which will have the added benefit of enhancing the search
for effective treatment of HIV disease in all children. Because many
HIV-positive children are without families to effectively advocate for
them, we must create a new structure for advocacy and decisionmak-
child, despite authorization by HHS regulations. See, e.g., Robert E. Cooke, Clinical Research
on Children, in ISSUES IN RESEARCH WITH HUMAN SUBJECTS 109 (1980).
The ethical issues raised by the use of prisoners and the poor seem simple when
compared to the problems involved in the use of children and other non-
competents. In order to develop certain kinds of drugs or procedures we can do
all the animal and adult testing we want and still we must finally test on
children-i.e., a test group who by definition cannot give informed consent. Paul
Ramsey has argued that no one, parent or guardian, even with the best intentions
has the moral status to consent for a child to be made the subject of medical
investigation solely for the accumulation of knowledge (except when epidemic
conditions prevail). To quote: "Where there is no possible relation to the child's
recovery, a child is not to be made a mere object in medical experimentation for
the good to come." If it is objected that this severely restricts possible advances
in childhood medicine, Ramsey argues that the moral progress of the race is
more important than the scientific. Thus, testing of children is the paradigm
instance that at times it may be necessary to choose between morality and
knowledge even though we normally assume that we do not have to choose
between them.
Id. at 109 (quoting Stanley Hauerwas, Must a Patient Be a "Person" to Be a Patient. Or My
Uncle Charlie Is Not Much of a Person but He is Still My Uncle Charlie, 39 CONN. MED. 815,
815-17 (1975)).
91. 45 C.F.R. § 46.409 (1990).
92. Id.
1991]
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ing. Involving members of the child's community as advocates is the
alternative most likely to result in responsible and sensitive
decisionmaking.
